Insmed Announces Fourth Quarter and Full-Year 2007 Financial Results
... by the revenues lost from our withdrawal of IPLEX(TM) from the short stature market pursuant to the terms of our Settlement Agreement. The net loss ... of goods sold resulted from our withdrawal of IPLEX(TM) from the short stature market, while the higher R&D Expenses reflected an increase in our ...Video: Axel Ullrich Named Winner of 2009 Dr. Paul Janssen Award for Biomedical Research
... was approved in 2006 for the treatment of kidney carcinoma and gastro-intestinal stromal tumors. "It is an honor to receive an award of this stature and to be recognized among so many outstanding scientists," said Ullrich. "Dr. Paul is a legend whose work had a tremendous impact on combating some ...Renowned Stem Cell Researcher Files Study Results With Stemedica
... President and Chief Medical Officer. "We are delighted with the outcomes for this study as well as the insights that someone of Dr. Hernigou's stature can bring to a study of this kind", Dr. Tankovich commented. The year-long study conducted by Dr. Hernigou and his staff included sixty ...Insmed Announces Fourth Quarter and Full-Year 2008 Financial Results
... MMD trial. This was partially offset by the absence of license income from Napo and the revenues lost from our withdrawal of IPLEX(TM) in the short stature market pursuant to the terms of our settlement agreement with Genentech Inc. and Tercica Inc., entered into in March 2007. The net loss for the ...State-of-the-art electron microscope promises to aid major research advances
... that allows for the clearest possible views yet of matter at the atomic level. The capabilities of this type of microscope will bolster ASU's stature as one of the top university microscopy research and teaching facilities in the nation. It is the first time the NSF is supporting acquisition of an ...Insmed Announces Financial Results for Third Quarter and Nine-Months Ended September 30, 2008
... MMD trial. This was partially offset by the absence of license income from Napo and the revenues lost from our withdrawal of IPLEX(TM) in the short stature market pursuant to the terms of our settlement agreement with Genentech Inc. and Tercica Inc., entered into in 2007. The net loss for the nine ...Neurofocus Appoints Stephen Kosslyn to Its Advisory Board
... papers, and is one of the founding fathers of the field of cognitive neuroscience. "We are privileged to have someone of Dr. Kosslyn's stature lending his presence to our Advisory Board," said Dr. A. K. Pradeep, Chief Executive Officer of NeuroFocus. "It underscores our foundation as the ...Human Genome Sciences Announces Process Development and Manufacturing Alliance With Hospira
... development capabilities to help advance and supply biopharmaceutical products for Hospira. We are pleased to be chosen by a company of Hospira's stature for such an important role," said Curran Simpson, Senior Vice President of Operations, HGS. "The priority focus of HGS continues to be the ...Insmed Announces Financial Results for Second Quarter and Six-Months Ended June 30, 2008
... in Italy. This was partially offset by the absence of license income from Napo and the revenues lost from our withdrawal of IPLEX(TM) in the short stature market pursuant to the terms of our settlement agreement with Genentech Inc. and Tercica Inc. entered into in 2007. The net loss for the six months ...Governor Perdue Announces Georgia Selected as Home for New National Health Museum
... Institution adds to Georgia's growing stature as crossroads of global health SAN DIEGO, June 18 /PRNewswire/ -- Governor Sonny Perdue today announced that ...Nuevolution Announces Research and Development Collaboration with Merck & Co. Inc.
... royalties on the commercial sales of approved products. Further financial details were not disclosed. "We are delighted that a company of Merck's stature has chosen to enter into collaboration with Nuevolution to access our fragment-based Chemetics(R) platform, which we believe has the potential to ...Insmed Announces First Quarter 2008 Financial Results
... associated with our business restructuring plan. The elimination of the cost of goods sold resulted from our withdrawal of IPLEX(TM) from the short stature market. The lower R&D Expenses reflected the reduced operating costs at our manufacturing facility located in Boulder, Colorado as we streamlined the ...John Marshall and Kevin McGuinness Appointed to Ellex Board
... excellent additions to the Ellex board during a period of growth and transition," said Victor Previn, Chairman of the Board at Ellex. "John's global stature and track record developing new technologies in ophthalmology will help Ellex identify and act on the best opportunities to leverage our ophthalmic ...NFL Hall of Fame Legend Fred Biletnikoff Joins AFL/Signalife Cardiovascular Protection Team
... every family in America and costs the U.S. Health Care industry about $400 billion per year in treating cardiovascular disease. Having someone of his stature -- a true NFL legend -- and of his demographic, will assist Signalife and AFL in addressing all of the different possible disease states and ...Connecture's Maynard finds IT business opportunity in adversity
... "The Riverwood name and picture of the office building would portray stature and stability," Maynard recalled in a recent interview. Next he and his ... The education of Dan Maynard Connecture did not reach that stature by chance. Although Maynard's formal education is in management ...Pre-eminent, web-based companies owe success to corporate venturing
... But the Milwaukee-based company might never have attained that stature or gotten off the ground at all had it not been for corporate venturing . ... existing infrastructure. The parent company's connections and stature helped, too. As ER doctors, we were able to discuss our idea at ...Third Wave strikes deal with Kaiser Permanente on cystic fibrosis reagents
... the companys existing Invader cystic fibrosis screen. The immediate adoption of this new product by an organization of Kaiser Permanente's stature clearly validates the value of the technology and further positions Third Wave in the molecular diagnostic market," said John Puisis, president and ...Fred Astaire and Ginger Rogers in the mosh pit
... We could hope for some CIO to waltz in, search for some sympathetic business executive or wait on some other common business-rescue fantasy. But the stature of IT and its relationships with the rest of the organization are at least partly in our hands. In dealing with people trapped in unsatisfying and ...Outsourcing fills gaps and drives U.S. back toward innovation
... Columbus was looking for India, too. Totally branded and totally outsourced While corporate America is slowly slipping in its international stature for being too caught up in its own internal battles of ideologies, principals and re-alignments, it is equally poised to capture a brand-new reality ...Space port could open in Sheboygan in next 10 years
... becoming, and how big of an industry its becoming, and suddenly it all became a lot more clear, Kanavas said. And the proposal could boost Wisconsins stature when it comes to the manufacturing of aerospace equipment, as well as generating tourism dollars. One businessman enthusiastic about the proposal ...Midwest gaining stature in nanotech research
... Although the Midwest is not conventionally known as one of the leading biotechnology clusters in the U.S., it appears to be gaining attention and stature in a related field: nanotechnology ! Granted, there is overlap between biotech and nanotech, but certainly not all nanotech is biotech and ...Financing life science: The ongoing saga
... we will look at life science funding around the U.S. See you soon! Recent articles by Michael Rosen Michael Rosen: Midwest gaining stature in nanotech research Michael Rosen: Midwest colleges strong contenders for NIH funds Michael Rosen: Japan on the rebound: Implications ...2006: A great biotech financing year, unless you were going public!
... more music! Recent articles by Michael Rosen Michael Rosen: Financing life science: The ongoing saga Michael Rosen: Midwest gaining stature in nanotech research Michael Rosen: Midwest colleges strong contenders for NIH funds Michael Rosen: Japan on the rebound: Implications ...2006: A mixed blessing for Midwest life science companies
... financing year, unless you were going public! Michael Rosen: Financing life science: The ongoing saga Michael Rosen: Midwest gaining stature in nanotech research Michael Rosen: Midwest colleges strong contenders for NIH funds Michael Rosen: Japan on the rebound: Implications ...A Midwest small-cap, life-science surprise package
... financing year, unless you were going public! Michael Rosen: Financing life science: The ongoing saga Michael Rosen: Midwest gaining stature in nanotech research Deborah Wilcox: The press vs. Google: Copyright cases to watch Michael S. Rosen is president of Rosen Bioscience ...The 10 biggest events shaping biotech in 2006
... financing year, unless you were going public! Michael Rosen: Financing life science: The ongoing saga Michael Rosen: Midwest gaining stature in nanotech research Michael S. Rosen is president of Rosen Bioscience Management, a company that provides CEO services, including financing ...Energy conservation might take us farther than renewable fuels
... haven't changed in years. Trains still stop at certain locations on every run, even though the location is not important anymore or has lost its stature as a major employment center. Cut back on the non-important stops. If riders have figured this out on their daily commute, what is wrong with the ...